DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac Amyloidosis
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Subjects Suspected of Having Familial Amyloidotic Cardiomyopathy (FAC)
Males or females >18 years old
History of evidence suggestive of cardiac amyloidosis
Subject is willing and able to comply with protocol required assessments and provide written informed consent
Known diagnosis of primary (AL) amyloidosis
Known diagnosis of hereditary cardiomyopathy or cardiomyopathy due to aortic stenosis